1,369 results on '"Walmsley, Sharon"'
Search Results
2. Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves
3. Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial
4. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials
5. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
6. Mpox in people with past infection or a complete vaccination course: a global case series
7. Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIV
8. Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial
9. COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series
10. The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination
11. Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328)
12. Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada
13. Mpox in people with advanced HIV infection: a global case series
14. Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
15. Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging
16. Un cas de variole simienne chez l'humain au Canada
17. Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
18. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada
19. Prevalence and Correlates of Frailty Among Older Adults Living With HIV in the CHANGE HIV Cohort.
20. A case of human monkeypox in Canada
21. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series
22. Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning
23. Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease
24. Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study
25. Frequent disengagement and subsequent mortality among people living with HIV and Hepatitis C in Canada: A prospective cohort study
26. Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study
27. Non-AIDS-defining comorbidities impact health related quality of life among older adults living with HIV
28. Previous Syphilis Not Associated with Neurocognitive Outcomes in People Living with HIV in Ontario, Canada
29. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
30. The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management
31. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial
32. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
33. Urinary symptoms and quality of life in women living with HIV: a cross-sectional study
34. HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition
35. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
36. Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks
37. Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity.
38. Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial
39. Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: Qualitative process evaluation of the Enhanced Syphilis Screening Among HIV-positive Men trial
40. Navigating complex care for older women with HIV: role of geriatrician support
41. Randomized, Blinded, Placebo-Controlled Trial of De Simone Formulation Probiotic During HIV-Associated Suboptimal CD4+ T Cell Recovery
42. Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals
43. 'We can hardly even do it nowadays. So, what's going to happen in 5 years from now, 10 years from now?' The health and community care and support needs and preferences of older people living with HIV in Ontario, Canada: a qualitative study
44. Urinary Eicosanoid Metabolites in HIV‐Infected Women with Central Obesity Switching to Raltegravir: An Analysis from the Women, Integrase, and Fat Accumulation Trial
45. Age-related experiences of diverse older women living with HIV: A scoping review protocol informed by intersectionality.
46. Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination.
47. Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study.
48. ADAPTING COGNITIVE REMEDIATION GROUP THERAPY AS A HYBRID INTERVENTION FOR PEOPLE WITH HIV AND COGNITIVE CONCERNS
49. Mindfulness and cognitive training interventions that address intersecting cognitive and aging needs of older adults
50. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.